Inosita 100MG Tablets 10s
KSh719.90KSh880.00 (-18%)
In stock
| Brand | Inosita |
| Active Ingredient | Sitagliptin 100mg |
| Strength | 100mg Tablets |
| Indication | Type 2 Diabetes Mellitus |
| Form | Oral Tablets |
| Prescription | Required |
| Common Side Effects | Headache, Upper respiratory infection |
| Serious Risks | Pancreatitis, Allergic reactions |
Inosita 100MG Tablets 10s
Inosita 100mg Tablets are an oral medication containing Sitagliptin, a DPP-4 inhibitor that helps adults with type 2 diabetes mellitus achieve better glycemic control. Sitagliptin works by increasing insulin release and decreasing glucagon levels in a glucose-dependent manner, helping lower blood sugar levels.
When combined with a balanced diet and regular exercise, Inosita provides an effective solution for managing type 2 diabetes. It can be used alone (monotherapy) or in combination with other anti-diabetic drugs, as prescribed by your healthcare provider.
Key Features
-
Active Ingredient: Sitagliptin 100mg
-
Formulation: Oral tablets
-
Indication: Type 2 diabetes mellitus
-
Mechanism of Action: DPP-4 inhibitor that enhances insulin secretion and lowers blood glucose
-
Prescription: Required
Key Uses of Inosita 100mg Tablets
-
Management of type 2 diabetes
-
Improves blood sugar control when combined with diet and exercise
-
Can be used as monotherapy or alongside other diabetes treatments (e.g., metformin)
Mechanism of Action
Sitagliptin works by inhibiting the DPP-4 enzyme, which leads to an increase in incretin hormones, thereby enhancing insulin release and reducing glucagon secretion in a glucose-dependent manner.
Dosage & Administration
-
Typical Dose: 100mg once daily
-
Administration: Oral tablet
-
Combining with other treatments: Can be combined with other diabetic medications as directed by your healthcare provider.
-
Dosage Adjustments: Based on blood sugar levels and individual response to treatment.
Important Precautions
-
Not for use in type 1 diabetes or diabetic ketoacidosis
-
Contraindicated for those allergic to Sitagliptin
-
Not recommended for children under 18 years of age
-
Monitor for side effects: Common effects may include upper respiratory tract infections, headache, and nasopharyngitis.
Possible Side Effects
-
Common: Upper respiratory infections, headache, nasopharyngitis
-
Serious: Pancreatitis, allergic reactions, kidney problems (seek medical attention if symptoms persist)

Reviews
There are no reviews yet.